Q1 2026 Holdings
Filed 2026-05-15 | 84 holdings | $522.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-05-18) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $50.9M | 1,035,496 | 9.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $34.9M | 313,791 | 6.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $28.4M | 1,215,743 | 5.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $27.4M | 281,632 | 5.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $18.5M | 746,494 | 3.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $18.1M | 56,267 | 3.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $14.9M | 499,469 | 2.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $14.4M | 533,378 | 2.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $14.2M | 363,438 | 2.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $13.9M | 205,622 | 2.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $13.5M | 1,594,491 | 2.6% |
| Surrozen Inc(SRZN)A | COM NEW | 86889P208 | $13.5M | 525,639 | 2.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $10.7M | 385,800 | 2.0% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $10.5M | 810,764 | 2.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.7M | 413,792 | 1.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $9.7M | 200,267 | 1.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $9.3M | 669,685 | 1.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $9.2M | 506,075 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.2M | 290,864 | 1.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.5M | 129,577 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $8.5M | 167,606 | 1.6% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $8.2M | 426,561 | 1.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.2M | 140,755 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.1M | 254,267 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.6M | 72,577 | 1.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.4M | 193,177 | 1.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $7.2M | 85,502 | 1.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $6.9M | 60,062 | 1.3% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $6.2M | 325,483 | 1.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $5.9M | 338,654 | 1.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $5.8M | 180,658 | 1.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.4M | 242,566 | 1.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $5.1M | 185,435 | 1.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $5.1M | 229,566 | 1.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.9M | 315,226 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $4.5M | 753,520 | 0.9% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $4.4M | 193,777 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.2M | 200,919 | 0.8% |
| Sensei Biotherapeutics Inc(SNSE) | COM NEW | 81728A207 | $4.2M | 132,873 | 0.8% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $4.2M | 597,409 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.9M | 239,861 | 0.7% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $3.8M | 15,415 | 0.7% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $3.5M | 850,742 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.4M | 59,061 | 0.7% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $3.2M | 939,369 | 0.6% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $3.1M | 305,028 | 0.6% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $3.0M | 188,700 | 0.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.8M | 80,492 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $2.4M | 86,637 | 0.5% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.4M | 1,874,546 | 0.5% |